4//SEC Filing
LAROCHE RICHARD F JR 4
Accession 0001437749-22-011337
CIK 0001047335other
Filed
May 5, 8:00 PM ET
Accepted
May 6, 3:56 PM ET
Size
25.8 KB
Accession
0001437749-22-011337
Insider Transaction Report
Form 4
LAROCHE RICHARD F JR
Director
Transactions
- Exercise/Conversion
Common Stock - Held in my name or my wife's name
2022-05-05$64.64/sh+2,500$161,600→ 194,313 total - Exercise/Conversion
Option to Purchase Common Stock
2022-05-05−2,500→ 0 totalExercise: $61.90From: 2018-05-03Exp: 2023-05-02→ Common Stock (2,500 underlying) - Exercise/Conversion
Option to Purchase Common Stock
2022-05-05−2,500→ 5,000 totalExercise: $64.64From: 2021-05-07Exp: 2025-05-06→ Common Stock (7,500 underlying) - Award
Option to Purchase Common Stock [2022 Grant]
2022-05-05+7,500→ 7,500 totalExercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying) - Exercise/Conversion
Common Stock - Held in my name or my wife's name
2022-05-05$61.90/sh+2,500$154,750→ 0 total
Holdings
- 30,000(indirect: General Partner)
Common Stock - Family LP (BFLP)
- 31,698
Common Stock - Fam. Partnership (LR Ent.)
- 96,000(indirect: General Partner)
Common Stock - Fam. Partnership (LFLP)
- 7,500
Option to Purchase Common Stock
Exercise: $72.94From: 2017-05-09Exp: 2022-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock
Exercise: $77.92From: 2019-05-09Exp: 2024-05-08→ Common Stock (7,500 underlying)
Footnotes (5)
- [F1]These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F2]Transactions for this "Title of Security" totaled on the line below.
- [F3]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
- [F4]Total amount of shares beneficially owned following transactions reported for this "Title of Securities" on this form.
- [F5]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
Documents
Issuer
NATIONAL HEALTHCARE CORP
CIK 0001047335
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001012859
Filing Metadata
- Form type
- 4
- Filed
- May 5, 8:00 PM ET
- Accepted
- May 6, 3:56 PM ET
- Size
- 25.8 KB